Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Diego Albani, Gianluigi Forloni, Panagiotis Ferentinos, Dan Rujescu, Julien Mendlewicz, Diana De Ronchi, Alessandro Serretti, Concetta Crisafulli
Topics & Concepts
CYP2C19MedicinePharmacogeneticsDepression (economics)AntidepressantConfoundingCYP2D6Side effect (computer science)Rating scaleInternal medicinePharmacologyMajor depressive disorderPsychiatryGenotypePsychologyCytochrome P450BiologyGeneticsGeneAmygdalaDevelopmental psychologyProgramming languageMetabolismComputer scienceHippocampusMacroeconomicsEconomicsPharmacogenetics and Drug MetabolismHormonal Regulation and HypertensionTreatment of Major Depression